Eliem Therapeutics Total Current Assets 2021-2024 | CLYM
Eliem Therapeutics total current assets from 2021 to 2024. Total current assets can be defined as the sum of all assets that are classified as current because they will provide a benefit within one year.
Eliem Therapeutics Annual Total Current Assets
(Millions of US $) |
| 2023 |
$110 |
| 2022 |
$134 |
| 2021 |
$148 |
| 2020 |
$22 |
Eliem Therapeutics Quarterly Total Current Assets
(Millions of US $) |
| 2024-06-30 |
$226 |
| 2024-03-31 |
$109 |
| 2023-12-31 |
$110 |
| 2023-09-30 |
$112 |
| 2023-06-30 |
$114 |
| 2023-03-31 |
$120 |
| 2022-12-31 |
$134 |
| 2022-09-30 |
$133 |
| 2022-06-30 |
$133 |
| 2022-03-31 |
$133 |
| 2021-12-31 |
$148 |
| 2021-09-30 |
$159 |
| 2021-06-30 |
$105 |
| 2021-03-31 |
|
| 2020-12-31 |
|
| 2020-09-30 |
|
| 2020-06-30 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-DRUGS |
$0.342B |
$0.000B |
|
Eliem Therapeutics Inc. is a clinical-stage biotechnology company. It focused on developing novel therapies for neuronal excitability disorders to address unmet needs in chronic pain, psychiatry, epilepsy and other disorders of the peripheral and central nervous systems. Eliem Therapeutics Inc. is based in SEATTLE, United Kingdom.
|
